HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $12 Price Target

0.00% Pre

Sensus Healthcare, Inc.

SRTS

0.00

HC Wainwright & Co. analyst Yi Chen reiterates Sensus Healthcare (NASDAQ: SRTS) with a Buy and maintains $12 price target.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Morgan Stanley Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $51

If You Invested $1000 In Boston Scientific Stock 5 Years Ago, You Would Have This Much Today

Is It Too Late To Consider Medtronic After Its Strong 2025 Share Price Rally?

Reported Earlier, Kestra Medical Technologies Prices $138M Upsized Primary Public Offering Of 6M Common Shares At $23 Per Share

electroCore CEO Daniel S. Goldberger Acquires Common Shares

Globus Medical (GMED): Reassessing Valuation After Recent Share Price Momentum

Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

BTIG Maintains Buy on Masimo, Raises Price Target to $200